TELA
Tela Bio Inc
1.10$
-8.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.6% | -8.0% | -16.2% | -11.9% | +64.7% | -11.5% | -12.6% | -8.8% | +32.2% | -14.2% | -14.5% | |
| – | -12.8% | -12.7% | -18.4% | -13.7% | +76.9% | -10.7% | -12.9% | -7.7% | +34.9% | -14.9% | -15.3% | |
| – | -19.7% | -20.5% | -28.7% | -34.7% | +204.4% | -18.7% | -18.3% | -15.0% | +71.1% | -22.2% | -23.1% | |
| – | -19.7% | -20.5% | -28.7% | -34.7% | +204.4% | -18.7% | -18.3% | -15.0% | +71.1% | -22.2% | -23.1% | |
| – | +20.6% | +5.3% | -8.4% | +23.7% | -13.1% | +15.4% | +7.5% | +5.1% | -21.5% | -6.1% | -0.8% | |
| – | -8.1% | +3.3% | -1.7% | +1.7% | -6.0% | +5.9% | -16.0% | +1.6% | -4.7% | +10.9% | -9.4% | |
| – | -4.3% | -4.5% | -4.7% | -4.9% | -5.2% | -5.5% | -5.8% | -6.1% | -6.5% | -7.0% | -7.5% | |
| – | +4.2% | -2.9% | -0.2% | +3.4% | -0.7% | +0.4% | -1.3% | +2.9% | +25.1% | 0.0% | +0.7% | |
| – | +10.6% | -10.5% | -1.3% | +12.5% | -7.5% | +6.0% | +15.3% | -10.9% | +5.9% | -0.8% | +2.2% | |
| – | +63.8% | +0.5% | +0.5% | -2.1% | -2.5% | -2.4% | +623.9% | -86.5% | – | – | +0.6% | |
| – | -46.1% | +101.4% | -31.1% | +7.1% | -13.4% | +86.4% | -56.5% | +36.3% | -2.7% | +68.6% | -26.0% | |
| – | +0.4% | +0.4% | +0.4% | +0.4% | +0.4% | +0.4% | -7.8% | +9.0% | +34.1% | +0.4% | +0.4% | |
| – | -38.2% | -23.8% | -80.0% | -318.5% | – | -36.3% | -49.3% | -83.0% | +305.5% | -182.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.4% | +0.3% | +0.2% | +62.2% | +13.0% | +0.2% | +0.1% | +13.8% | +10.8% | +0.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.